Pioderma gangrenoso multifocal y exuberante

• Dávila Rodríguez, J.J. ^[1] ; García, L. ^[2] ; Aguilar Benavides, K. ^[2] ; Aguilar, Y. ^[2]
  1. [1] Universidad Central del Ecuador

     Universidad Central del Ecuador

     Quito, Ecuador

     
  2. [2] Servicio de Dermatología, Hospital Carlos Andrade Marín, Quito, Ecuador
• Localización: Piel: Formación continua en dermatología, ISSN 0213-9251, Vol. 34, Nº. 8 (OCTUBRE), 2019, págs. 506-508
• Idioma: español
• DOI: 10.1016/j.piel.2018.09.008
• Títulos paralelos:
  • Multifocal and exuberant pyoderma gangrenosum
• Enlaces
  • Texto Completo Ejemplar
• Referencias bibliográficas
  • Alavi A, French LE, Davis MD, Brassard A, Kirsner RS. Pyoderma Gangrenosum: An Update on Pathophysiology Diagnosis and Treatment. Am J Clin...
  • Monari P, Moro R, Motolese A, Misciali C, Baraldi C, Fanti PA, et al. Epidemiology of pyoderma gangrenosum: Results from an Italian prospective...
  • Ahn C, Negus D, Huang W. Pyoderma gangrenosum: A review of pathogenesis and treatment. Expert Rev Clin Immunol. 2018;14:225–33.
  • Vallini V, Andreini R, Bonadio A. Pyoderma Gangrenosum: A Current Problem as Much as an Unknown One. Int J Low Extrem Wounds. 2017;16:191–201.
  • Vacas AS, Bollea-Garlatti ML, Torre AC, Galimberti RL. Bullous pyoderma gangrenosum as a predictor of hematological malignancies. An Bras...
  • Braswell SF, Kostopoulos TC, Ortega-Loayza AG. Pathophysiology of pyoderma gangrenosum (PG): An updated review. J Am Acad Dermatol. 2015;73:691–8.
  • Gameiro A, Pereira N, Cardoso JC, Gonc¸alo M. Pyoderma gangrenosum: Challenges and solutions. Clin Cosmet Investig Dermatol. 2015;8:285–92.
  • Wollina U. Pyoderma gangrenosum-a systemic disease? Clin Dermatol. 2015;33:527–30.
  • Kridin K, Cohen AD, Amber KT. Underlying Systemic Diseases in Pyoderma Gangrenosum: A Systematic Review and Meta-Analysis. Am J Clin Dermatol....
  • Ahronowitz I, Harp J, Shinkai K. Etiology and management of pyoderma gangrenosum: a comprehensive review. Am J Clin Dermatol. 2012;13:191–211.
  • Su WP, Davis M, Weenig RH, Powell FC, Perry HO. Pyoderma gangrenosum: clinicopathologic correlation and proposed diagnostic criteria. Int...
  • Feldman SR, Lacy FA, Huang WW. The safety of treatments used in pyoderma gangrenosum. Expert Opin Drug Saf. 2018;17:55–61.
  • McKenzie F, Cash D, Gupta A, Cummings LW, Ortega-Loayza AG. Biologic and small molecule medications in the management of pyoderma gangrenosum....